
Tilos Therapeutics
Tilos is developing new immuno-oncology therapies for cancer, fibrosis and autoimmunity based on interference with regulatory T cells and TGF release. This novel drug platform builds on the discovery that antibodies that block the release of TGF prevent immune suppression, thereby enabling the body to counteract malignant cells.